253 related articles for article (PubMed ID: 33791970)
1. Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.
Li XR; Xiu MH; Guan XN; Wang YC; Wang J; Leung E; Zhang XY
Neurotherapeutics; 2021 Apr; 18(2):1316-1324. PubMed ID: 33791970
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
Liu H; Yu R; Gao Y; Li X; Guan X; Thomas K; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1774-1782. PubMed ID: 34544343
[TBL] [Abstract][Full Text] [Related]
3. Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study.
Liu H; Liu H; Jiang S; Su L; Lu Y; Chen Z; Li X; Li X; Wang X; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1793-1803. PubMed ID: 34766896
[TBL] [Abstract][Full Text] [Related]
4. Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy.
Wang K; Xiu M; Su X; Wu F; Zhang X
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453331
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.
Noto C; Ota VK; Gadelha A; Noto MN; Barbosa DS; Bonifácio KL; Nunes SO; Cordeiro Q; Belangero SI; Bressan RA; Maes M; Brietzke E
J Psychiatr Res; 2015 Sep; 68():210-6. PubMed ID: 26228421
[TBL] [Abstract][Full Text] [Related]
6. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
7. Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study.
Xiu M; Song X; Yang H; Huang X; Wu F; Zhang X
Curr Neuropharmacol; 2023; 21(10):2151-2158. PubMed ID: 37132112
[TBL] [Abstract][Full Text] [Related]
8. Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study.
Gao Z; Xiu M; Liu J; Wu F; Zhang X
Curr Neuropharmacol; 2024; 22(10):1733-1741. PubMed ID: 37859307
[TBL] [Abstract][Full Text] [Related]
9. Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.
Fan N; Tan Y; Yang F; Tian L; Chen S; Li J; Wang Z; Zhang X
Neurosci Lett; 2017 May; 650():168-173. PubMed ID: 28419824
[TBL] [Abstract][Full Text] [Related]
10. Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia.
Li Z; Hu M; Zong X; He Y; Wang D; Dai L; Dong M; Zhou J; Cao H; Lv L; Chen X; Tang J
Sci Rep; 2015 Dec; 5():18553. PubMed ID: 26680692
[TBL] [Abstract][Full Text] [Related]
11. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
[TBL] [Abstract][Full Text] [Related]
12. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia.
Djordjević VV; Kostić J; Krivokapić Ž; Krtinić D; Ranković M; Petković M; Ćosić V
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295651
[TBL] [Abstract][Full Text] [Related]
13. Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.
Tsai MC; Liou CW; Lin TK; Lin IM; Huang TL
Psychiatry Res; 2013 Oct; 209(3):284-90. PubMed ID: 23497820
[TBL] [Abstract][Full Text] [Related]
14. Smoke, GPx activity and symptoms improvement in patients with drug-naive first-episode schizophrenia: A large-scale 12-week follow-up study.
Chen N; Liu H; Yao J; Chen S; Xiu M; Wu F; Zhang X
Asian J Psychiatr; 2022 Nov; 77():103267. PubMed ID: 36202003
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
Chen YQ; Li XR; Zhang L; Zhu WB; Wu YQ; Guan XN; Xiu MH; Zhang XY
J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004092
[TBL] [Abstract][Full Text] [Related]
16. Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.
Raffa M; Atig F; Mhalla A; Kerkeni A; Mechri A
BMC Psychiatry; 2011 Aug; 11():124. PubMed ID: 21810251
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis.
Yang M; Wang C; Zhao G; Kong D; Liu L; Yuan S; Chen W; Feng C; Li Z
Curr Neuropharmacol; 2023; 21(2):340-352. PubMed ID: 35794775
[TBL] [Abstract][Full Text] [Related]
18. Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
Hu M; Zong X; Zheng J; Mann JJ; Li Z; Pantazatos SP; Li Y; Liao Y; He Y; Zhou J; Sang D; Zhao H; Tang J; Chen H; Lv L; Chen X
Psychol Med; 2016 Sep; 46(12):2549-60. PubMed ID: 27338296
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
